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Abstract 
 
Recently more and more evidence suggests that rare variants with much lower minor 
allele frequencies play significant roles in disease etiology. Advances in next-generation 
sequencing technologies will lead to many more rare variants association studies. Several 
statistical methods have been proposed to assess the effect of rare variants by aggregating 
information from multiple loci across a genetic region and testing the association between 
the phenotype and aggregated genotype. One limitation of existing methods is that they 
only look into the marginal effects of rare variants but do not systematically take into 
account effects due to interactions among rare variants and between rare variants and 
environmental factors. In this article, we propose the summation of partition approach 
(SPA), a robust model-free method that is designed specifically for detecting both 
marginal effects and effects due to gene-gene (G×G) and gene-environmental (G×E) 
interactions for rare variants association studies. SPA has three advantages. First, it 
accounts for the interaction information and gains considerable power in the presence of 
unknown and complicated G×G or G×E interactions. Secondly, it does not sacrifice the 
marginal detection power; in the situation when rare variants only have marginal effects 
it is comparable with the most competitive method in current literature. Thirdly, it is easy 
to extend and can incorporate more complex interactions; other practitioners and 
scientists can tailor the procedure to fit their own study friendly. Our simulation studies 
show that SPA is considerably more powerful than many existing methods in the 
presence of G×G and G×E interactions.  
 
 
Introduction 
 
Despite of the success of large scale biological studies such as GWAS in discovering 
many disease variants, most of which are common variants with minor allele frequency 
(MAF) greater than 0.05, for diabetes, heart disease, Alzheimer disease, etc., the variants 
identified thus far confer relatively small risk, explain a small fraction of familial 
clustering, and add little practical value in disease prediction. The issue of so-called 
“missing heritability” has been a serious concern that has attracted considerable attention 
and discussion recently. [1,2,3,4,5] A number of explanations have been suggested for 
this phenomenon including: (1) an as-yet undiscovered larger set of variants of smaller 
effects, (2) rare variants with larger effects that may be eluding the current GWAS, (3) 
unaccounted effects, due to gene-gene (G×G) and gene-environment (G×E) interactions, 
(4) undetected structure effects including copy number variations (CNVs), and (5) over-
estimated heritability.[6,7,8,9,10,11] This article presents a simple yet easy-to-extend 
method to address issues (2) and (3). 
 
In genetic association studies, the ‘common-disease common-variants’ (CDCV) model 
states that common diseases are caused by common variants with MAFs greater than 5% 
or 1%. [12] However, recently more and more evidence supports the alternative 
‘common-disease rare-variants’ (CDRV) hypothesis which claims that complex disorders 
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are caused by multiple rare variants with MAF < 1%. [13,14] Unlike common variants 
that do not affect protein function directly, most rare variants are missense mutations in 
promoter region or protein coding regions and they are capable of altering gene 
expression level, changing amino acids sequence and affecting protein-protein 
interactions. [15,16] Furthermore, rare variants may have higher odds ratios (above 2), 
compared with small odds ratios (1.1~1.5) of common variants. [17] Therefore, the 
investigation of rare variants will help researchers further understand the disease etiology 
and may provide new insights into medical treatments. With the development and 
commercialization of next generation sequencing technologies, large number of SNPs 
with low frequencies can be detected in a relatively short time and at relatively low cost. 
[5] In the near future, whole-genome sequencing will become possible for large numbers 
of individuals, and, as a result, large amounts of sequence data with rare variants will be 
generated. Methods that are capable of detecting these casual variants are very much in 
need. 
 
Due to the low frequencies and large number of rare variants, traditional single-marker 
association tests that have worked well for common variants will in general lack power 
for rare variants. [18] In recent years, several statistical methods have been developed 
based on collapsing rare variants in a specific region of interest, e.g. a gene or genes from 
a specific pathway, followed by performing a region-based test rather than individual 
tests for each variants. The Combined Multivariate and Collapsing (CMC) method 
proposed by Li and Leal [19] tests whether the proportions of rare variants carriers in 
cases and controls are significantly different. The weighted sum (WS) method by Madsen 
and Browning [20] is designed to weight variants according to their estimated frequencies 
in controls, so that less frequent variants receive higher weights compared with more 
common variants. Instead of using the conventional cutoff values 0.05 or 0.01 to define 
rare variants, Price et al. [21] proposed to choose a variable threshold (VT) that gives an 
optimal testing power. Ionita-Laza et al. [22] developed a replication-based (RB) 
approach, also based on a weighted-sum statistic, that can be more powerful in the 
presence of both risk and protective variants. Wu et al. proposed a sequence kernel 
association test (SKAT) that is a score-based variance component test. [23] SKAT uses a 
linear weighted kernel 
 
K(Gi ,Gi ' ) = wjGijGi ' j
j=1
K
∑ to measure the similarity between 
individuals i  and i '  (K is the number of markers and wj is the weight of SNP j  ). A 
weighted quadratic kernel 
 
K(Gi ,Gi ' ) = 1+ wjGijGi ' j
j=1
K
∑
⎛
⎝⎜
⎞
⎠⎟
2
was also proposed in [23] to 
account for both main effects and genetic interaction effects but it was not systematically 
studied. Many alternative methods that have also been proposed can be considered 
variations of these approaches. [24,25,26] 
 
Why another approach? The aforesaid methods have been shown to work well in 
different simulated models (mostly with marginal effects only). However, all these tests 
only consider marginal effects from rare variants and they do not systemically address the 
issue of interactions among rare variants (G×G), or between rare variants and covariates, 
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such as environmental factors (G×E). Therefore, additional statistical methods are needed 
to generate scientific knowledge on the etiology of complex diseases where interactions 
among genetic, biological and environmental variables work together to produce a 
phenotype. In this article, we propose the summation of partition approach (SPA), a 
robust model-free method that not only tests the marginal effects of rare SNPs but also 
naturally incorporates G×G and G×E interactions. As with existing methods, SPA is 
based on aggregating information across rare variants in a region of interest. We shall 
demonstrate the power of SPA and compare with existing methods for both dichotomous 
and quantitative phenotypes. Simulation studies show that in disease models without 
interactions, the performance of SPA is comparable to or even better than the most 
competitive existing method in current literature, and in the presence of G×G interactions, 
SPA substantially outperforms all the other methods. Another advantage of our procedure 
is its simplicity and extensibility. We also demonstrate in this article how to incorporate 
an environmental factor in the proposed framework and show that the augmented test 
score is powerful in detecting G×E interactions. Similar approaches can be taken to 
account for interactions with common variants or other covariates. In addition, we 
compare the proposed method with several existing tests on the dataset provide by 
Genetic Analysis Workshop 17 (GAW17) and find that SPA is robust for detecting 
different genes. When large volumes of datasets with rare variants become available in 
the near future, the proposed procedure will become a powerful tool to detect 
complicated interaction effects in various genetic regions and it will help us to better 
understand the mechanisms of complex human diseases. 
 
 
Materials and Methods 
 
To better understand the motivation and rational behind SPA, we briefly review a general 
framework that has been adopted for detecting common variants with interactions. A core 
element in this framework is the influence score I  derived from what we now know as 
the Partition Retention (PR) method. [27] Several forms and variations were associated 
with the PR method before it was finally coined this name in 2009. 
 
A General Framework Used for Detecting Common Variants 
We demonstrate a basic tool adopted by our method. Suppose there are n subjects with a 
response variable Y and K discrete explanatory variables {X1,…, XK} . If each Xi  can take 
three discrete values, we generate a partition Π with 3K non-overlapping partition 
elements. Let ni be the number of subjects in partition i, Y i  the average response for 
subjects in partition i, and Y  the average response from all subjects.  An influence 
measure between the response and the predictors is defined as: 
I(X1,...,XK ) = ni2 Yi −Y( )2
i∈Π
∑  
It has been shown that under the null hypothesis that none of the predictors has influence 
on Y, the normalized I, I / (nσ 2 ) (σ 2  denotes the variance of Y) is asymptotically 
distributed as a weighted sum of χ 2  random variables of 1 degree of freedom each such 
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that the total weight is less than 1. [27] The main structure of this measure is the partition 
formed by the K discrete variables with 3K partition elements each containing non-
overlapping observations. This influence measure captures any discrepancy between the 
conditional mean and the grand mean of Y and thus is able to detect X-Y association 
regardless of the structure of dependence.  It can be easily generalized to any discrete 
random variables with finite number of outcomes. 
 
In case-control studies, the influence measure can be rewritten as: 
I = ni2 pˆiD −
NA
NA + NU
⎛
⎝⎜
⎞
⎠⎟
2
i∈Π
∑  
where NA is the number of affected individuals,  NU is the number of unaffected 
individuals, and pˆiD is the proportion of cases in partition i. Several variations of this 
partition-based method have been successful at identifying influential common variants 
and their interactions in human diseases, such as Rheumatoid Arthritis [28,29,30] and 
breast cancer [31,32]. Its success in detecting common variants relies on the essence that 
many partition cells contain more than singleton subjects, however, this property will 
diminish for rare variants due to their extremely low frequencies. To effectively deal with 
rare variants, we need to modify the partition procedure properly to accommodate for the 
sparseness, which can be achieved by the proposed summation of partition approach 
(SPA). We introduce below several test statistics of SPA, including the marginal test 
score I1, G×G interaction score I2, and G×E interaction scores I2*  .  
 
Rare Variants Marginal Association Score I1 
The general framework mentioned above can be extended to rare variants association 
analysis for both dichotomous and continuous phenotypes.  
 
In population-based case-control studies, suppose there are N unrelated individuals, 
among which NA are cases and NU  = N - NA are controls. The region of interest G 
contains K rare variants and the genotype of the jth  individual is denoted (X1( j ),...,XK( j ) ) . 
Each Xi( j ) (i =1,...,K )  can take values 0, 1 or 2, indicating the number of rare variants at 
this position. The SPA test score I1 that accounts for all marginal information contributed 
by these K rare SNPs is defined as 
I1 = ni2 pˆiD −
NA
NA + NU
⎛
⎝⎜
⎞
⎠⎟
2
i=1
K
∑  
where pˆiD , for the ith  SNP, is the fraction of all observed rare variants that are from cases, 
and ni is the total number of i
th rare variant observed in all subjects.  
 
For continuous traits, I1 is defined as  
I1 = ni2 Yi −Y( )2
i=1
K
∑  
where Y i , for the ith  SNP, is the averaged response for subjects bearing at least one rare 
variant, Y  is the averaged response from all subjects and ni is defined as above. Different 
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from the original influence measure, I1 recognizes the partition elements formed by 
individual SNP and hence the partitions from different SNPs are not non-overlapping any 
more; therefore, I1 does not suffer from the sparseness of rare variants. Under the null 
hypothesis of no influence, the differences between pˆiD and
 
NA
NA + NU   
for dichotomous 
traits (or between Yi  and Y  for continuous traits) for all i are small, so a large I1 value 
indicates that some rare variants in the region might be associated with the disease 
phenotype. Additionally, since each term of I1 is the squared difference between the 
conditional average and the grand average, it can detect both directions of departure from 
the expected difference zero, which renders I1 the ability to capture the association even 
in a region with both risk and protective rare variants. Unlike PR’s influence measure I, 
the statistical property of I1 is more complicated to obtain since the dependence between 
partition cells created by different SNPs will not asymptotically disappear even under the 
null hypothesis of no influence. Therefore, in our analyses we will rely on the method of 
permutation to assess its statistical significance. 
 
Rare Variants G×G Interaction Association Score I2 
In order to increase the power of detecting the genotype-phenotype associations as well 
as to elucidate the biological pathways that underpin disease, more and more attentions 
have been given to the identification of interactions between SNP loci. [33,34,35] A 
limitation of I1 is that it considers little interactions among rare SNPs. From the general 
framework, we propose a second SPA test score I2 that evaluates G×G interactions 
among rare variants. 
 
As the genotype at each SNP position can take 3 values, in theory we are facing a 
maximum of 3K partition elements for all levels of interactions. However, due to the low 
frequencies of rare variants, the higher order (>2) interaction information among rare 
SNPs in current sample size will be small. For example, if the sample size is 1,000 and 
the SNP frequency is 0.01, the expected number of observing one specific rare variants 
triplet is 1,000×0.013 = 10-3. If a region contains 20 independent rare SNPs, the expected 
total number of rare variants triplets would be 203
⎛
⎝⎜
⎞
⎠⎟
× 0.001= 1.14 , which provides 
very low signal for 3-way interaction detection. Therefore, for current sample size, we 
only consider an influence measure that takes into account 2-way interactions among rare 
variants. For a pair of rare SNPs i and j, we consider three aggregated cells: individuals 
with rare variants only on SNP i (denoted mM), individuals with rare variants only on 
SNP j (denoted Mm) and individuals with rare variants on both SNPs (denoted mm). Note 
that we do not consider the cell MM where individuals have no rare variant at either 
position. For dichotomous trait, the SPA test score I2 for G×G interaction is defined as 
I2 = nij2 pˆij ,mMD −
NA
NA + NU
⎛
⎝⎜
⎞
⎠⎟
2
+ pˆij ,MmD −
NA
NA + NU
⎛
⎝⎜
⎞
⎠⎟
2
+ pˆij ,mmD −
NA
NA + NU
⎛
⎝⎜
⎞
⎠⎟
2⎡
⎣
⎢
⎢
⎤
⎦
⎥
⎥i≥1, j>i
K
∑
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where n ij  is the number of subjects who have at least one rare variant in either SNP (i or 
j), pˆij,mMD  is the fraction of subjects that are cases in partition mM, pˆij,MmD  is that fraction in 
partition Mm, and pˆij,mmD  in partition mm. For quantitative trait, I2 is defined as 
 
I2 = nij2 Yij ,mM −Y( )2 + Yij ,Mm −Y( )2 + Yij ,mm −Y( )2⎡⎣⎢ ⎤⎦⎥i≥1, j>i
K
∑  
where Yij,mM  is the average response for individuals in partition mM, Yij,Mm  in partition 
Mm, and Yij,mm  in partition mm. If two rare variants have interactions, the difference 
between the conditional average and the unconditional average will be large, leading to a 
large I2 value. Again, permutation is used to evaluate the significance of the test statistic 
I2. Even though I2  only considers 2-way interaction, it can be easily extended to include 
higher-order (≥3) interactions by generating partitions based on m-tuples (m≥3) of rare 
SNPs.  
 
Adaptive Test Score p* 
When we are unclear whether G×G interaction is involved in the onset of disease, we 
propose an adaptive score p* that is a compromise between I1 and I2. We first evaluate 
the significance of I1 and I2. Then the adaptive test score is defined as:  
p*  =  min(p(I1),  p(I2 ))  
where p(I1) and p(I2) are the p-values of I1 and I2 separately. We evaluate the significance 
of p* by permutation.  
 
Rare Variants G×E Interaction Association Score I2
*  
Increasing evidence has shown that gene and environmental (G×E) interactions are 
widely involved in the etiology of complex diseases, including diabetes, cancer and 
psychiatric disorders [36,37,38,39,40]. Conventional methods to detect G×E interactions 
are mostly based on regression models, which will lose power for rare variants. SPA can 
be easily extended to incorporate covariates, such as environmental factors in the testing 
procedure, considering both the environmental marginal effect and the G×E interaction 
information. Here we focus on case-control study design. Suppose an environmental 
factor E has J levels. The SPA test score for detecting the effect of the environmental 
factor is expressed as: 
I2* = ni, j2  pˆi, jD −
NA
NA + NU
⎛
⎝⎜
⎞
⎠⎟
2
i=1
K
∑
j=1
J
∑  
where pˆi, jD  is the fraction of rare variants at position i on level j that are from cases, and 
n i, j is the total number of ith rare variants observed at level j.  I2
*  is a modification of I1 by 
building additional overlapping rare variants partition cells to J non-overlapping 
partitions created by the environmental factor. The significance of  I2
* is evaluated by 
permutation. We propose two permutation strategies: (1) global permutation that 
permutes the phenotype among all individuals; and (2) local permutation that permutes 
the phenotype within each stratum of the environmental factor. Both permutation 
strategies are investigated in our study.
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Simulation Scheme 
We simulated several scenarios for the purpose of evaluation and comparison of our test 
scores with several existing rare variants association methods. The genotype consists of 
20 independent rare variants in each scenario. Scenario ‘Null-1’ is a ‘null model’ where 
none of the 20 variants affects the phenotype. For dichotomous traits, the phenotypes are 
determined by the baseline penetrance only. This is the null setting for I1, I2, p* and  I2
*  
with global permutation. In scenario ‘Null-2’, the dichotomous outcomes are affected by 
the environmental factor. ‘Null-2’ is the null setting for  I2
* with local permutation.  
 
For empirical power comparisons, we generate three different sets of simulations. The 
first set of simulations are marginal effect models, in which the MAF of all SNPs are 
uniformly distributed between 0.0001 and 0.01. In scenario 1, 5 out of the 20 rare SNPs 
are risk SNPs and the effect size is constant. Scenario 2 is similar to scenario 1 except 
that the risk effect is negatively correlated with MAF. Scenario 3 has 5 protective 
variants and 5 deleterious variants with effect size negatively correlated with MAF. The 
second set of simulations contains 2-way G×G interaction between rare variants, with 
MAF 0.01 for all 20 SNPs. In scenario 4, 50% of the SNPs (10 out of 20 SNPs) have 
interaction effects. Scenario 5 is similar to scenario 4 but 75% of the SNPs are involved 
in G×G interactions. Both main effect and G×G interaction effect exist in scenario 6. The 
third set of simulation models involves G×E interaction effects with a binary 
environmental factor. Scenario 7 has positive G×E interaction effects and environmental 
marginal effect; scenario 8 has both positive and negative G×E interaction effects. 
Logistic regressions or linear regression was used to generate dichotomous or 
quantitative phenotypes. 1,000 repetitions were simulated for each scenario with four 
different sample sizes, each having equal number of cases and controls. Detailed 
simulation models are provided in Table S1 in file S1. 
 
Results 
 
We compared the power of SPA test scores I1, I2 and p* with existing methods: CMC, 
WS, VT, RB SKAT (with the weighted linear kernel) and SKATint (a modified SKAT 
score with the weighted quadratic kernel) in a series of simulation scenarios, including 
marginal effect models and G×G interaction effect models for both dichotomous traits 
and continuous traits. RB only deals with binary outcomes, so it is not included in our 
analysis for continuous traits. We also evaluated the power of  I2
*  in G×E interaction 
effect models for dichotomous traits. (See Material and Methods for details of simulation 
models; numerical results from our simulation studies are presented in Table S2-S7 in file 
S1.) 
 
Type I Error of I1, I2 and p* 
The empirical type I error rates for I1, I2 and p* are presented in Table 1 for nominal 
levels α=0.05 and α=0.01 with four different sample sizes: 600, 1000, 1500 and 2000. 
The results show that I1, I2 and p* are well controlled at both significance levels for either 
dichotomous or continuous trait, even when the sample size is small, indicating that the 
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proposed tests are valid methods. Additional results of type I error for competing 
methods are presented in Fig. S1 in file S1.  
 
Power Comparison in Marginal Effect Models for both Dichotomous and 
Continuous Traits 
We compare the power of I1, I2 and p* with competing methods in three marginal effect 
models when (1) only risk variants exist and the effect size is constant, (2) only risk 
variants exist and the effect size is negatively correlated with MAF, or (3) a mixture of 
risk and protective rare variants exists.  
 
In all three marginal effect scenarios, the performance of I1 and SKAT are comparable 
and they are both superior to the other tests (Fig. 1, 2 and 3). For dichotomous traits, I1 is 
the most powerful method, followed by SKAT and p*. For continuous traits, SKAT and 
I1 are most competitive; both of them are more powerful than the other methods.  The 
power of the adaptive score p* is very close to I1,; p* is much more powerful than CMC, 
WS, VT and RB. In addition, I1 and p* are quite robust to different simulation scenarios, 
even in the presence of a mixture of risk and protective variants, while CMC, WS and VT 
suffer substantial power loss when causal rare variants have opposite effects (Fig. 3). It is 
worth noting that although I1 does not intentionally highlight less frequent variants by 
giving them higher weights, it is still the most powerful (for dichotomous trait) or the 
second most powerful (for quantitative traits) method even in scenarios where the effect 
size is negatively correlated with MAF, showing that its good performance is intrinsic 
and is not driven by a specific weighting scheme. The test score I2 does not show a high 
power in these marginal effect models as it is designed to detect G×G interaction effects 
but not the marginal effect. 
 
Power Comparison for G×G Interaction Effect Models for both Dichotomous and 
Continuous Traits 
We evaluated the power of different methods in two G×G interaction effect models 
(scenarios 4 and 5). The advantage of the G×G interaction association score I2 over all the 
other methods is apparent for both dichotomous and continuous traits (Fig. 4 and Fig. 5). 
For dichotomous traits, when the sample size is large, the power of I2 is substantially 
higher than all the other methods. For continuous traits, I2 is uniformly the most powerful 
method for all sample sizes; for example, when the sample size is 2000, I2 is 38% more 
powerful than SKATint at α = 0.01. Moreover, the adaptive score p* has a power that is 
just slightly less than I2 , and p* is substantially more powerful than the rest. On the other 
hand, VT, WS and CMC suffer from significant loss of power in the presence of 
complicated G×G interaction effects.  
 
We also examine the scenario in which the phenotypes are influenced by both genetic 
marginal and G×G interaction effects (scenario 6). Here the marginal effect is set to be 
small so that it will not mask the interaction effect. I2 is still consistently the most 
powerful test and p* is the second best, followed by SKATint (Fig. 6). For continuous 
traits with sample size 2000, I2 is 29% more powerful than SKATint, and p* is 28% more 
powerful than SKATint at α = 0.01. 
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Type I Error and Power of  I2
*  for Dichotomous Trait 
For the G×E interaction score  I2
* , we investigated its type I error and power for 
dichotomous trait using two permutation strategies – global permutation and local 
permutation (see Materials and Methods), denoted by  I2
* -Global and  I2
* -Local 
respectively.  As  I2
*  considers both the genetic and environmental marginal effects as 
well as G×E interaction effect,  I2
* -Global is appropriate for testing the null hypothesis of 
no association at all (no G marginal, E marginal or G×E interaction effects), and  I2
* -
Local is appropriate for testing the null hypothesis of no E marginal effect. 
 
The type I error of  I2
*  are evaluated for two null hypotheses. The first null hypothesis 
(null-1) assumes the dichotomous traits are completely determined by the baseline 
penetrance. The second null hypothesis (null-2) assumes that the phenotypes are affected 
by environmental marginal (E marginal) effect. Table 2 presents the type I error of  I2
* -
Global and  I2
* -Local in these two null settings. In null-1, both  I2
* -Global and  I2
* -Local 
are correctly controlled at levels α=0.05 and 0.01. In null-2,  I2
* -Local still hits the target 
level while  I2
* -Global has significant higher values. This is because  I2
* -Global is able to 
test any effect from genetic or environmental factors, including the E marginal effect; 
hence the results of  I2
* -Global in null-2 are indeed the power of  I2
* -Global in the 
presence of E marginal effect. On the other hand,  I2
* -Local removes the E marginal effect, 
so it shows the correct type-I error in both null-1 and null-2.  
 
Two scenarios are considered to compare the power of  I2
* -Global,  I2
* -Local and 
competing methods when (1) the phenotypes are affected by E marginal effect and 
positive G×E effect, (2) the phenotypes are affected by E marginal effect and both 
positive and negative G×E effects. In computation, SKAT and SKATint regress the 
phenotype on the environmental factor when calculating the test statistic [23].   I2
* -Global 
and  I2
* -Local use the environmental factor as in their definition. All the other methods 
work on the phenotype and the genotype directly. The results show that  I2
* -Global has 
much higher power than all the other tests because it takes into account both E marginal 
and G×E interaction effects, and  I2
* -Local outperforms all the remaining methods that do 
not consider G×E interaction effects (Fig. 7).  
 
Application to the GAW17 Dataset 
The genetic analysis workshop 17 (GAW17) provided genotypes of 3,205 autosomal 
genes on 697 individuals from the 1000 Genome Project. A dichotomous phenotype was 
simulated from a linear model using SNPs from 34 genes and most causal SNPs were 
rare variants. A total of 200 simulation replicates were carried out and the genotype was 
held fixed for all replicates. See [41] for more details of the simulation model. Here we 
chose to re-analyze two causal genes FLT1 and ANRT. In the workshop, FLT1 has been 
shown to exhibit a strong signal in many well-known methods while ARNT could not be 
identified by any existing approach. For both genes, an upper frequency of 0.05 was used 
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as the MAF cutoff to define rare variants and only nonsynonymous SNPs were examined. 
We computed the power of our test scores and competing methods using all 200 
replicates.  Power was calculated as the proportion of replicates with p-value less than 
0.05 out of the 200 simulations. As shown in Table 3, I1 was fairly robust for detecting 
both genes. For FLT1, two count-based collapsing methods – CMC and WS are most 
powerful, followed by VT and I1. For ARNT, I1 is substantially more powerful than the 
other methods – its power is  47% higher than the second best method SKAT. Given that 
the simulated model is a simple additive linear model with genetic marginal effects only, 
methods considering G×G interactions, including I2 and SKATint, do not have apparent 
advantages in power gain for detecting either FLT1 or ARNT.  
 
Computation Time 
The computation time of I1, I2 and p* depends on the sample size, the number of variants 
and the number of permutations. On a 2.66GHz laptop with 4GB memory, to reach a 
significance level of 10-4, the computation times to analyze a region with 20 SNPs for 
600, 1000, 1500 and 2000 individuals are 3, 5, 7, 10 sec for I1, and are about 1000, 1400, 
1900, 2500 sec for I2.  
 
Discussion 
 
We propose here the summation of partition approach (SPA), a flexible robust model-free 
framework for rare variants association analysis that incorporates both G×G and G×E 
interactions. The proposed SPA test scores create partitions from individual SNP and 
combine the information across all rare variants in a region of interest. I1 is designed to 
detect marginal effects of rare variants and I2 is designed to capture the G×G interaction 
effects among rare variants. In various marginal effect models, I1 is more powerful than 
most approaches examined in our study. Its performance is comparable to SKAT, which 
is regarded as the most competitive existing method. In G×G interaction models or in the 
scenario with both marginal and G×G interaction effects, I2 is superior to all the other 
methods in terms of detection power. The adaptive score p* is a compromise between I1 
and I2 and has the advantage of both test scores. Its performance is just a little shy of the 
better of the two scores I1 and I2, for both marginal effect models and interaction effect 
models. Therefore, p* is a self-tuning adaptive score that is able to gain power 
automatically regardless of the simulation scenario. In practice when we have no clue of 
how the genotype affects the phenotype, we suggest to use the adaptive score p*. A 
significant p-value of p* indicates a potential true signal from either marginal or 
interaction effects of rare variants.  In our study, we focus on the situation with 20 rare 
SNPs. If the SNP number changes to 30, the simulation results (Fig. S2 in file S1) are 
qualitatively similar in that I1 is the most powerful in marginal effect models and I2 is the 
most powerful in interaction effect models.  
 
 I2
*  is an augmented score of I1 that incorporates covariates. It can be used to test the 
hypothesis of no association at all (neither G marginal, E marginal nor G×E effect) using 
‘global permutation’ or to test the hypothesis of no E marginal effect using ‘local 
permutation’. By ‘local permutation’,  I2
*  removes the marginal effect of the 
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environmental factor while still captures variations of the genetic effect at different levels 
of the environmental factor. In a similar fashion, covariates can be incorporated into I2 
and the resulting augmented score could be used to detect E×G×G 3-way interactions 
between an environmental factor and two rare variants.  
 
 I2
*  can also be used to test the interaction effect between common and rare variants if one 
treats the common variant as an environmental factor. It can be further extended to detect 
3-way interactions among the environmental factor, common and rare variants by 
building additional overlapping partitions based on rare variants on top of the non-
overlapping partition cells generated by the environmental factor and the common variant. 
A global permutation can detect both main and interaction effects of these factors, and a 
local permutation that permutes the phenotype within each non-overlapping partition cell 
will capture the E×common×rare 3-way interaction effect.  
 
 I2
*  deals with categorical covariates naturally. In order to handle continuous covariates, 
such as age, height and BMI, we suggest taking the discretization approach that divides 
continuous variables into distinct buckets. These ‘pseudo-categorical’ variables generated 
by discretization can be applied to  I2
*  directly. In practice, we usually set the number of 
buckets to be 2~5 and the results are quite satisfactory. Moreover, a new influence 
measure dealing with continuous covariates directly is under preparation.  
 
The insight of SPA is similar to the partition retention (PR) influence measure as in [27]. 
The PR method generates non-overlapping partition elements over the sample space and 
assigns each partition cell a weight that is proportional to the probability of falling into 
that cell. Its success in detecting influential variables relies on the essence that weights 
are not too small for all partition elements, especially for those cells that generate signals. 
Therefore, the PR method may lose power for rare variants association studies as the 
partition cells with true signals will have very low weights due to the extremely low 
frequencies of rare variants. SPA differs from the PR method by creating overlapping 
partition elements to avoid the sparseness and to boost the signal from rare variants.  
 
The information measure I1 can be viewed as a special case of 
I1 = wini pˆiD −
NA
NA + NU
⎛
⎝⎜
⎞
⎠⎟
2
i=1
K
∑  
where {wi}are weights that sum to 1. Weights can be defined in various ways. The 
inherent choice we take here is wi = ni ni
i=1
K
∑ . If external information is available on 
possible effects of a rare variant to disease, it is straightforward to incorporate such 
information in our test approach by tuning the weight. Some commonly used weights are 
based on (1) MAF of the variant as in [20]; or (2) externally-defined weights such as 
predictions from SIFT and PolyPhen, as suggested by Price et al. [21]. In our study, even 
though we do not incorporate the weight information, SPA is still superior over the other 
methods. We believe that after tuning the weight, SPA will exhibit a better performance.  
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Population stratification has been shown to be an important problem for common variant 
association analysis. For rare variants, this problem is more likely to occur due to their 
low frequency and possible uneven distribution among populations. It is straightforward 
to control population stratification in our approach as we can consider population as an 
environmental factor and apply it to  I2
* . An alternative is to treat population with PCA 
and include the discretized eigenvalues in our analysis.  
 
A major advantage of SPA is that it is highly extensible. The building blocks of SPA are 
the partitions formed by individual rare variant and it is easy to incorporate complex 
interactions. As demonstrated in the article, we are able to take into account interactions 
with environmental factors. Similar approaches can be applied when considering 
interactions with common variants or other covariates. It can also be generalized to other 
research areas to benefit the practitioners and scientists in various fields. We believe that 
the proposed framework of SPA will offer substantial opportunities in detecting potential 
complicated interactions. Once interaction effects indeed exist, our approach is capable of 
identifying these interactions and thus adding to the detection power.  
 
This paper presents a simple novel (and easily implemented) tool SPA as an alternative to 
existing statistical methods for rare variants association studies, with a unique additional 
feature that SPA can easily incorporate various forms of interaction effects. This addition 
may add considerable power to disease-related detection in the future. From our studies, 
if the underlying model is a simple linear additive model with only marginal effects, the 
powers of SPA are comparable to several existing methods. However, if the model is 
more complex with interaction effects, the proposed approach provides a more powerful 
alternative in rare variants association analysis so that there is a better chance to find 
disease-associated factors. With the development of next-generation sequencing 
techniques, more and more data with a large amount of rare variants will be generated. It 
is highly unlikely that the disease phenotype is associated with genetic factors through a 
simple linear main effect model, so the proposed approach is going to be a powerful and 
rewarding tool to explore the complicated interaction effects revealed by larger datasets. 
It is worth noting that any interaction pattern, whether it is linear or nonlinear, can be 
detected by SPA, since it is model-free and is not subject to any distribution assumptions. 
Therefore, it is very robust and effective regardless of how the genotype affects the 
phenotype. The R code of the proposed test scores is available to download at 
http://www.columbia.edu/~rf2283/Software.html 
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Tables 
Table 1. Type I error estimates of  I1 ,  I2 and  p*  
 
Dichotomous Trait 
 α=0.05 α=0.01 
Sample Size I1   I2    p*   I1   I2    p*   
600 0.052 0.055 0.054 0.009 0.012 0.009 
1000 0.053 0.055 0.053 0.010 0.010 0.010 
1500 0.048 0.049 0.049 0.007 0.007 0.007 
2000 0.053 0.057 0.053 0.010 0.013 0.010 
Continuous Trait 
 α=0.05 α=0.01 
Sample Size I1   I2    p*   I1   I2    p*   
600 0.055 0.055 0.058 0.013 0.011 0.013 
1000 0.05 0.046 0.044 0.009 0.005 0.010 
1500 0.061 0.048 0.061 0.015 0.011 0.010 
2000 0.045 0.046 0.043 0.013 0.009 0.009 
 
 
 
 
Table 2. Type I error estimates of  I2
*  in two different null settings 
Null-1: No G, E or G×E Effects 
 α=0.05 α=0.01 
Sample Size  I2
* -Global  I2
* -Local  I2
* -Global  I2
* -Local 
600 0.053 0.050 0.007 0.007 
1000 0.047 0.046 0.009 0.007 
1500 0.045 0.048 0.008 0.009 
2000 0.043 0.044 0.009 0.009 
Null-2 : Marginal Environmental Effect only 
 α=0.05 α=0.01 
Sample Size  I2
* -Global a   I2
* -Local  I2
* -Global a   I2
* -Local 
600 0.110 0.046 0.027 0.007 
1000 0.169 0.050 0.058 0.012 
1500 0.239 0.047 0.087 0.011 
2000 0.282 0.046 0.114 0.017 
a This is actually the power of I2
* -Global in the presence of marginal environmental effect.  
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Table 3. Power of two genes in GAW17 dataset 
 FLT1 ARNT 
#Rare NSb SNPs 19 (10 causal) 9 (5 causal) 
I1 0.865 0.345 
I2 0.505 0.05 
p* 0.775 0.22 
SKAT 0.82 0.235 
SKATint 0.77 0.1 
RB 0 0.005 
VT 0.88 0.025 
WS 0.95 0.075 
CMC 0.95 0.055 
                                                bNS: nonsynonymous 
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Figures 
 
 
Figure 1. Power comparison in the marginal effect model when the effect sizes are 
constant. Powers were calculated for nominal α levels 0.05 (left) and 0.01(right) and for 
dichotomous traits (upper) and continuous traits (lower). Powers were evaluated for I1, I2, 
p*, SKAT, SKATint, VT, RB, WS and CMC. Scenarios with different sample sizes were 
considered. P-values were estimated using 10,000 permutations and power was evaluated 
using 1,000 replicates. 
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Figure 2. Power comparison in the marginal effect model when the effect sizes of 
causal variants are negatively correlated with MAFs. Powers were calculated for 
nominal α levels 0.05 (left) and 0.01(right) and for dichotomous traits (upper) and 
continuous traits (lower). Powers were evaluated for I1, I2, p*, SKAT, SKATint, VT, RB, 
WS and CMC. Scenarios with different sample sizes were considered. P-values were 
estimated using 10,000 permutations and power was evaluated using 1,000 replicates. 
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Figure 3. Power comparison in the marginal effect model with a mixture of 
protective and risk rare variants. Powers were calculated for nominal α levels 0.05 
(left) and 0.01(right) and for dichotomous traits (upper) and continuous traits (lower). 
Powers were evaluated for I1, I2, p*, SKAT, SKATint, VT, RB, WS and CMC. Scenarios 
with different sample sizes were considered. P-values were estimated using 10,000 
permutations and power was evaluated using 1,000 replicates. 
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Figure 4. Powers are calculated for nominal α levels 0.05 (left) and 0.01(right) and for 
dichotomous traits (upper) and continuous trait (lower). Power was evaluated for I1, I2, p*, 
SKAT, SKATint, VT, RB, WS and CMC. Scenarios with different sample sizes were 
considered. P-values were estimated using 10,000 permutations and power was evaluated 
using 1,000 replicates. 
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Figure 5. Power comparison in G×G interaction effect model when 75% of rare 
variants participate in the interaction effect. Powers are calculated for nominal α 
levels 0.05 (left) and 0.01(right) and for dichotomous traits (upper) and continuous trait 
(lower). Power was evaluated for I1, I2, p*, SKAT, SKATint, VT, RB, WS and CMC. 
Scenarios with different sample sizes were considered. P-values were estimated using 
10,000 permutations and power was evaluated using 1,000 replicates. 
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Figure 6. Power comparison in the scenario with both main effect and G×G 
interaction effect. Powers are calculated for nominal α levels 0.05 (left) and 0.01(right) 
and for dichotomous traits (upper) and continuous trait (lower). Power was evaluated for 
I1, I2, p*, SKAT, SKATint, VT, RB, WS and CMC. Scenarios with different sample sizes 
were considered. P-values were estimated using 10,000 permutations and power was 
evaluated using 1,000 replicates. 
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Figure 7. Power comparison in two G×E interaction models for dichotomous trait. 
Powers were calculated for nominal α levels 0.05 (left) and 0.01(right) when only 
positive G×E effects exist (upper) and when both positive and negative G×E effects exist 
(lower). Powers were evaluated for  I2
* (with both global and local permutations), I1, I2, p*, 
SKAT, SKATint, VT, RB, WS and CMC. Scenarios with different sample sizes were 
considered. P-values were estimated using 10,000 permutations and power was evaluated 
using 1,000 replicates. 
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Supporting Information  
Supplementary Tables: 
 
Table S1. Models to generate simulated phenotypes 
Null Models  
 Dichotomous Continuous 
Null-1 
(null setting for I1, 
I2, p* and  
I2
* -Global) 
log P(A)1− P(A)
⎛
⎝⎜
⎞
⎠⎟
= log(1 / 99)  y = 0.5*U1 + 0.5*U2 + ε  
Null-2 
(null setting for  
I2
* -Local) 
log P(A)1− P(A)
⎛
⎝⎜
⎞
⎠⎟
= log(1 / 99)+ log(2)*E
 
N/A 
Genetic Marginal Effect Models 
 Dichotomous Continuous 
Scenario 1 
(constant marginal 
effects) 
 
log P(A)1− P(A)
⎛
⎝⎜
⎞
⎠⎟
= log(1 / 99)+ log(3)* Xi
i=1
5
∑  y = 0.5*U1 + 0.5*U2 + 0.8* Xi
i=1
5
∑ + ε  
Scenario 2 
(marginal effects 
negatively 
correlated with 
MAF) 
 
log P(A)1− P(A)
⎛
⎝⎜
⎞
⎠⎟
= log(1 / 99)+ βiXi
i=1
5
∑  
where βi =| log10 MAF | *ln5 / 4
 y = 0.5*U1 + 0.5*U2 + βiXi
i=1
5
∑ + ε,  
where βi =| log10 MAF | *0.4
 
Scenario 3 
 (both positive and 
negative marginal 
effect) 
 
log P(A)1− P(A)
⎛
⎝⎜
⎞
⎠⎟
= log(1 / 99)+ βiXi
i=1
5
∑ − βiXi
i=6
10
∑
where βi =| log10 MAF | *ln5 / 4
 y = 0.5 *U1 + 0.5 *U2 + βiXii=1
5
∑ − βiXi
i=6
10
∑ + ε ,  
where βi =| log10 MAF | *0.4
 
G×G Interaction Effect Models 
 Dichotomous Continuous 
Scenario 4  
(50% SNPs 
participate in G×G 
interaction effects) 
 
log P(A)1− P(A)
⎛
⎝⎜
⎞
⎠⎟
= log(1 / 99)+
log5* I(Xi > 0,Xj > 0)*(−1)i
j=6
10
∑
i=1
5
∑ ,  
 
y = 0.5*U1 + 0.5*U2 +
1.5* I(Xi > 0,Xj > 0)*(−1)i
j=6
10
∑
i=1
5
∑ + ε
 
Scenario 5  
(75% SNPs 
participate in G×G 
interaction effects) 
 
log P(A)1− P(A)
⎛
⎝⎜
⎞
⎠⎟
= log(1 / 99)+
log5* I(Xi > 0,Xj > 0)*(−1)i
j=7
15
∑
i=1
6
∑ ,
 
y = 0.5*U1 + 0.5*U2 +
1.5* I(Xi > 0,Xj > 0)*(−1)i
j=7
15
∑
i=1
6
∑ + ε
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Scenario 6  
(Both marginal and 
G×G interaction 
effects) 
 
log P( A)
1− P( A)
⎛
⎝⎜
⎞
⎠⎟
= log 1
99
+ βi Xi
i=1
2
∑ − βi Xi
i=3
5
∑⎛⎝⎜
⎞
⎠⎟
*0.1+
log5* I( Xi > 0, X j > 0)*(−1)
i
j=7
15
∑
i=1
6
∑
where βi =| log10 MAF | *ln5 / 4
 
 
y = 0.5*U1 + 0.5* U2+ βi Xi
i=1
2
∑ − βi Xi
i=3
5
∑⎛⎝⎜
⎞
⎠⎟
*0.1+ 1.5* I( Xi > 0, X j > 0)*(−1)
i
j=7
15
∑
i=1
6
∑ + ε
where βi =| log10 MAF | *0.4
 
G×E Interaction Effect Models 
 Dichotomous Continuous 
Scenario 7 (Positive 
G×E effect) 
 
log P(A)1− P(A)
⎛
⎝⎜
⎞
⎠⎟
= log(1 / 99)+ log(2)*E + βi *E *Xi
i=1
5
∑  
where βi =| log10 MAF | *ln5 / 4
 
N/A 
Scenario 8 (Positive 
and negative G×E 
effect) 
 
log P(A)1− P(A)
⎛
⎝⎜
⎞
⎠⎟
= log(1 / 99)+ log2 *E + βi *E *Xi
i=1
5
∑
− βi *E *Xi
i=6
10
∑  
where βi =| log10 MAF | *ln5 / 4
 
N/A 
We generated 20 independent SNPs with MAF uniformly distributed in 0.0001 and 0.01 except in scenarios 
4 and 5 where all the MAFs are set as 0.01. For models involving environmental factors, the environmental 
factor E is generated from a Bernoulli distribution with success probability 0.5. In models for continuous 
traits, U1~N(0,1) and U2~Bernoulli(0.5) are two covariates independent of genetic factors and ε~N(0,1) is 
the random noise.  
 
 
 
Table S2. Power of different methods for dichotomous traits in scenarios 1~6 (α=0.05) 
Scenario 
Sample 
Size CMC WS VT RB SKAT 
 
SKATint I1 
 
I2 
 
p* 
1 600 0.709 0.775 0.584 0.699 0.774 0.690 0.813 0.666 0.786 
1 1000 0.822 0.868 0.724 0.838 0.918 0.884 0.934 0.832 0.925 
1 1500 0.924 0.945 0.855 0.948 0.974 0.967 0.976 0.941 0.973 
1 2000 0.946 0.963 0.92 0.967 0.981 0.980 0.979 0.956 0.981 
2 600 0.474 0.533 0.366 0.442 0.504 0.449 0.537 0.402 0.512 
2 1000 0.683 0.740 0.545 0.694 0.744 0.688 0.768 0.621 0.742 
2 1500 0.773 0.807 0.680 0.791 0.862 0.832 0.856 0.718 0.834 
2 2000 0.889 0.916 0.813 0.913 0.957 0.950 0.956 0.874 0.948 
3 600 0.247 0.298 0.152 0.324 0.616 0.590 0.616 0.559 0.616 
3 1000 0.370 0.422 0.232 0.534 0.881 0.849 0.880 0.794 0.867 
3 1500 0.438 0.491 0.277 0.779 0.980 0.973 0.975 0.946 0.976 
3 2000 0.589 0.644 0.399 0.924 0.998 0.999 0.999 0.988 0.999 
4 600 0.063 0.088 0.077 0.088 0.079 0.094 0.083 0.087 0.088 
4 1000 0.080 0.108 0.099 0.094 0.099 0.112 0.105 0.128 0.124 
4 1500 0.087 0.123 0.101 0.133 0.147 0.165 0.157 0.238 0.207 
4 2000 0.084 0.122 0.112 0.143 0.156 0.200 0.168 0.311 0.271 
5 600 0.152 0.265 0.301 0.351 0.317 0.337 0.351 0.344 0.342 
5 1000 0.211 0.364 0.464 0.557 0.503 0.563 0.537 0.683 0.633 
5 1500 0.287 0.505 0.633 0.755 0.709 0.791 0.744 0.918 0.899 
5 2000 0.361 0.607 0.752 0.884 0.845 0.909 0.874 0.972 0.968 
6 600 0.165 0.285 0.314 0.361 0.319 0.352 0.347 0.363 0.360 
6 1000 0.222 0.372 0.455 0.567 0.493 0.579 0.536 0.689 0.646 
6 1500 0.278 0.503 0.628 0.771 0.740 0.803 0.784 0.929 0.890 
6 2000 0.349 0.567 0.726 0.886 0.871 0.923 0.890 0.976 0.972 
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Table S3. Power of different methods for dichotomous traits in scenarios 1~6 (α=0.01) 
Scenario 
Sample 
Size CMC WS VT RB SKAT 
 
SKATint I1 
 
I2 
 
p* 
1 600 0.470 0.541 0.364 0.494 0.604 0.492 0.664 0.452 0.629 
1 1000 0.651 0.699 0.556 0.677 0.812 0.743 0.832 0.662 0.817 
1 1500 0.804 0.838 0.732 0.865 0.937 0.914 0.942 0.846 0.938 
1 2000 0.869 0.898 0.802 0.928 0.960 0.954 0.961 0.894 0.957 
2 600 0.253 0.298 0.182 0.239 0.275 0.221 0.312 0.204 0.282 
2 1000 0.436 0.494 0.306 0.464 0.546 0.468 0.592 0.388 0.536 
2 1500 0.553 0.604 0.458 0.609 0.703 0.665 0.704 0.510 0.671 
2 2000 0.730 0.767 0.649 0.801 0.879 0.866 0.880 0.695 0.867 
3 600 0.101 0.134 0.049 0.139 0.376 0.349 0.383 0.327 0.366 
3 1000 0.170 0.207 0.091 0.291 0.711 0.669 0.717 0.607 0.700 
3 1500 0.224 0.270 0.139 0.502 0.918 0.906 0.915 0.854 0.912 
3 2000 0.353 0.400 0.233 0.767 0.986 0.987 0.986 0.960 0.986 
4 600 0.016 0.023 0.022 0.027 0.030 0.037 0.025 0.034 0.029 
4 1000 0.016 0.027 0.019 0.022 0.020 0.026 0.018 0.029 0.024 
4 1500 0.014 0.030 0.033 0.038 0.049 0.061 0.054 0.089 0.074 
4 2000 0.025 0.032 0.024 0.041 0.054 0.066 0.055 0.120 0.096 
5 600 0.047 0.099 0.138 0.172 0.141 0.160 0.153 0.169 0.172 
5 1000 0.062 0.159 0.255 0.320 0.260 0.323 0.290 0.434 0.400 
5 1500 0.105 0.248 0.404 0.534 0.504 0.589 0.561 0.781 0.752 
5 2000 0.143 0.352 0.545 0.712 0.678 0.769 0.722 0.934 0.910 
6 600 0.041 0.099 0.131 0.180 0.137 0.146 0.160 0.153 0.157 
6 1000 0.069 0.168 0.240 0.341 0.273 0.321 0.304 0.446 0.401 
6 1500 0.090 0.244 0.385 0.555 0.513 0.611 0.563 0.789 0.757 
6 2000 0.150 0.340 0.531 0.705 0.687 0.793 0.732 0.938 0.917 
 
 
Table S4. Power of different methods for continuous traits in scenarios 1~6 (α=0.05) 
Scenario 
Sample 
Size CMC WS VT SKAT 
 
SKATint I1 
 
I2 
 
p* 
1 600 0.409 0.568 0.523 0.604 0.584 0.583 0.445 0.544 
1 1000 0.608 0.744 0.716 0.838 0.824 0.817 0.642 0.790 
1 1500 0.763 0.873 0.874 0.945 0.949 0.927 0.752 0.913 
1 2000 0.833 0.933 0.939 0.970 0.971 0.956 0.778 0.952 
2 600 0.458 0.626 0.597 0.710 0.682 0.694 0.593 0.679 
2 1000 0.668 0.839 0.831 0.892 0.891 0.874 0.774 0.851 
2 1500 0.815 0.926 0.922 0.977 0.976 0.970 0.892 0.958 
2 2000 0.919 0.971 0.977 0.989 0.990 0.982 0.932 0.981 
3 600 0.086 0.071 0.215 0.969 0.965 0.957 0.915 0.957 
3 1000 0.113 0.080 0.321 0.996 0.997 0.996 0.989 0.997 
3 1500 0.162 0.089 0.429 1.000 1.000 1.000 0.998 1.000 
3 2000 0.160 0.086 0.537 1.000 1.000 1.000 1.000 1.000 
4 600 0.045 0.041 0.050 0.118 0.193 0.110 0.296 0.252 
4 1000 0.052 0.044 0.048 0.142 0.250 0.144 0.449 0.392 
4 1500 0.059 0.045 0.061 0.178 0.294 0.174 0.579 0.508 
4 2000 0.045 0.034 0.056 0.200 0.363 0.206 0.695 0.629 
5 600 0.051 0.085 0.109 0.328 0.543 0.331 0.664 0.637 
5 1000 0.039 0.063 0.116 0.380 0.619 0.370 0.861 0.810 
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5 1500 0.051 0.090 0.119 0.504 0.742 0.509 0.952 0.926 
5 2000 0.045 0.081 0.150 0.631 0.844 0.627 0.987 0.980 
6 600 0.046 0.078 0.090 0.319 0.508 0.312 0.675 0.641 
6 1000 0.057 0.071 0.106 0.440 0.653 0.432 0.863 0.826 
6 1500 0.037 0.064 0.115 0.539 0.769 0.523 0.949 0.931 
6 2000 0.047 0.077 0.144 0.701 0.879 0.700 0.991 0.982 
 
 
Table S5. Power of different methods for continuous traits in scenarios 1~6 (α=0.01) 
Scenario 
Sample 
Size CMC WS VT SKAT 
 
SKATint I1 
 
I2 
 
p* 
1 600 0.211 0.334 0.294 0.377 0.344 0.362 0.206 0.334 
1 1000 0.403 0.514 0.492 0.680 0.655 0.663 0.401 0.631 
1 1500 0.559 0.688 0.697 0.859 0.864 0.832 0.538 0.813 
1 2000 0.673 0.803 0.823 0.929 0.932 0.912 0.552 0.891 
2 600 0.242 0.362 0.346 0.485 0.454 0.459 0.343 0.443 
2 1000 0.443 0.629 0.632 0.743 0.750 0.711 0.528 0.692 
2 1500 0.630 0.798 0.814 0.927 0.939 0.908 0.671 0.894 
2 2000 0.802 0.907 0.924 0.971 0.978 0.964 0.789 0.961 
3 600 0.028 0.012 0.081 0.892 0.869 0.864 0.776 0.860 
3 1000 0.035 0.028 0.172 0.993 0.989 0.990 0.948 0.985 
3 1500 0.054 0.024 0.249 1.000 1.000 0.999 0.989 0.999 
3 2000 0.069 0.026 0.361 1.000 1.000 1.000 0.996 1.000 
4 600 0.006 0.008 0.015 0.045 0.083 0.041 0.157 0.124 
4 1000 0.009 0.007 0.010 0.047 0.101 0.047 0.262 0.208 
4 1500 0.012 0.009 0.012 0.057 0.135 0.063 0.348 0.299 
4 2000 0.008 0.004 0.013 0.088 0.175 0.084 0.477 0.413 
5 600 0.008 0.030 0.029 0.147 0.321 0.138 0.509 0.453 
5 1000 0.009 0.019 0.027 0.192 0.409 0.190 0.694 0.646 
5 1500 0.012 0.018 0.035 0.278 0.518 0.279 0.854 0.825 
5 2000 0.015 0.026 0.048 0.430 0.676 0.420 0.947 0.928 
6 600 0.011 0.018 0.030 0.151 0.299 0.148 0.484 0.420 
6 1000 0.007 0.021 0.030 0.243 0.452 0.246 0.740 0.679 
6 1500 0.009 0.020 0.040 0.335 0.571 0.326 0.866 0.841 
6 2000 0.007 0.027 0.058 0.470 0.740 0.467 0.957 0.948 
 
 
Table S6. Power of different methods for dichotomous traits in G×E interaction effect 
models (α=0.05) 
Scenario 
Sample 
Size CMC WS VT RB SKAT SKATint I1 I2 p* 
I2
*
-
Global 
I2
*
-
Local 
7 600 0.299 0.337 0.209 0.239 0.218 0.220 0.219 0.178 0.207 0.543 0.362 
7 1000 0.418 0.468 0.323 0.377 0.338 0.324 0.408 0.309 0.386 0.852 0.593 
7 1500 0.551 0.601 0.439 0.547 0.438 0.434 0.580 0.425 0.550 0.967 0.770 
7 2000 0.636 0.679 0.515 0.609 0.543 0.521 0.653 0.487 0.646 0.968 0.813 
8 600 0.149 0.184 0.108 0.165 0.307 0.313 0.298 0.236 0.300 0.565 0.381 
8 1000 0.214 0.246 0.152 0.262 0.471 0.481 0.483 0.396 0.483 0.837 0.640 
8 1500 0.278 0.303 0.175 0.347 0.598 0.602 0.625 0.507 0.612 0.915 0.732 
8 2000 0.323 0.360 0.194 0.478 0.767 0.764 0.794 0.678 0.780 0.980 0.872 
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Table S7. Power of different methods for dichotomous traits in G×E interaction effect 
models (α=0.01) 
Scenario 
Sample 
Size CMC WS VT RB SKAT SKATint I1 I2 p* 
I2
*
-
Global 
I2
*
-
Local 
7 600 0.100 0.125 0.07 0.074 0.083 0.084 0.076 0.053 0.096 0.29 0.154 
7 1000 0.207 0.240 0.154 0.189 0.130 0.123 0.182 0.102 0.195 0.615 0.332 
7 1500 0.304 0.351 0.220 0.326 0.242 0.221 0.344 0.201 0.374 0.870 0.524 
7 2000 0.384 0.419 0.283 0.395 0.313 0.302 0.429 0.234 0.460 0.900 0.587 
8 600 0.048 0.060 0.033 0.048 0.125 0.131 0.107 0.070 0.132 0.309 0.172 
8 1000 0.081 0.097 0.054 0.104 0.251 0.253 0.234 0.176 0.288 0.643 0.361 
8 1500 0.123 0.134 0.058 0.152 0.376 0.374 0.379 0.254 0.425 0.765 0.501 
8 2000 0.126 0.146 0.072 0.222 0.548 0.557 0.556 0.412 0.616 0.940 0.676 
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Figure S1. Type I error for different methods in various sample sizes with nominal α 
levels 0.05 (left) and 0.01(right). Results for four sample sizes: 600, 1000, 1500 and 
2000, with equal numbers of cases and controls. 
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Figure S2. Power comparison in scenarios 1~6 for dichotomous traits with 500 cases 
and 500 controls when the SNP number is 30. Powers were calculated for nominal α 
levels 0.05 (left) and 0.01(right). Power was evaluated for I1, I2, p*, SKAT, SKATint, VT, 
RB, WS and CMC. P-values were estimated using 10,000 permutations and power was 
evaluated using 1,000 replicates. 
 
